#1
#1 out of 10.00%
health2h ago
‘Research here is world class’: son of Steve Jobs looks to invest in UK cancer care
- Reed Jobs launches UK-backed investment push with Yosemite to back oncology startups in the UK.
- LifeArc hosts Jobs at a London life sciences conference to discuss collaborations.
- Yosemite targets gene therapy, cancer vaccines, radiopharmaceuticals, and immunotherapy.
- Yosemite's funding comes from Amgen, MIT, Memorial Sloan Kettering, and John Doerr.
- Reed Jobs links personal cancer experience to his mission for early detection and targeted therapy.
- Jobs expects cancer to move from end-stage to early-detected and treated disease.
- Immunotherapy is a key area of Yosemite’s focus for future cancer care.
- Jobs aims to expand UK partnerships with LifeArc and universities like Oxford and Cambridge.
- Yosemite operates a donor-advised fund alongside its for-profit arm.
- Reed Jobs’ fund is backed by major investors and aims for global impact in oncology.
Vote 0